- $189.96bn
- $266.11bn
- $78.56bn
- 93
- 47
- 63
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 44,998 | 68,397 | 80,118 | 79,571 | 78,558 |
Cost of Revenue | |||||
Gross Profit | 26,477 | 40,783 | 45,546 | 47,559 | 49,010 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 39,276 | 61,761 | 73,226 | 73,028 | 64,292 |
Operating Profit | 5,722 | 6,636 | 6,892 | 6,543 | 14,266 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,603 | 3,530 | 3,351 | 3,146 | 10,999 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,468 | 2,744 | 3,024 | 2,590 | 8,317 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,468 | 3,064 | 3,024 | 2,590 | 8,317 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3,468 | 3,064 | 3,024 | 2,909 | 8,317 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.56 | 4.26 | 4.64 | 6.86 | 7.83 |